Skip to content

Insider · CIK 0001836654

Luke Corning

director

Files at PSTX (Poseida Therapeutics, Inc.). First filing -, latest -.

In brief

Luke Corning files SEC Form 4 as director at PSTX (Poseida Therapeutics, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.

A track record needs three past buys with six months of prices behind them; Luke Corning has 0, so none is measured yet.

Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 0
$0 bought, $0 sold

Signals

This insider’s open-market buys and sells, scored.

No scored open-market trades yet.

Transactions

Every row this insider has filed, 5 in all, newest first.

DateCompanyTransactionSharesPriceValueHoldings afterFiled
Jan 8, 2025PSTX
Poseida Therapeutics, Inc.
UTender of shares
Common Stock
-58,950--0Jan 8, 2025
Jan 8, 2025PSTX
Poseida Therapeutics, Inc.
DDisposition to issuer
Stock Option (Right to Buy)derivative
-45,833$0.00$00Jan 8, 2025
Jan 8, 2025PSTX
Poseida Therapeutics, Inc.
DDisposition to issuer
Stock Option (Right to Buy)derivative
-28,500$0.00$00Jan 8, 2025
Jan 8, 2025PSTX
Poseida Therapeutics, Inc.
DDisposition to issuer
Stock Option (Right to Buy)derivative
-27,350$0.00$00Jan 8, 2025
Jan 8, 2025PSTX
Poseida Therapeutics, Inc.
DDisposition to issuer
Stock Option (Right to Buy)derivative
-27,350$0.00$00Jan 8, 2025

Questions about Luke Corning

Answered from the filings on this page, as of the latest one.

Is Luke Corning buying or selling?

Luke Corning has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.

How did Luke Corning's past buys perform?

Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Luke Corning has 0.

Where does Luke Corning file Form 4?

Luke Corning has filed Form 4 at PSTX (Poseida Therapeutics, Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Luke Corning: insider trades and track record | InsiderTell